Cargando…

Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer

BACKGROUND: Our previous study revealed that Vav3 oncogene is overexpressed in human prostate cancer, activates androgen receptor, and stimulates growth in prostate cancer cells. The current study is to determine a potential role of Vav3 oncogene in human breast cancer and impact on estrogen recepto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Kiwon, Liu, Yin, Mo, Jun Qin, Zhang, Jinsong, Dong, Zhongyun, Lu, Shan
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430719/ https://www.ncbi.nlm.nih.gov/pubmed/18518979 http://dx.doi.org/10.1186/1471-2407-8-158

Ejemplares similares

Estrogen Induces Vav1 Expression in Human Breast Cancer Cells
por: Du, Ming-juan, et al.
Publicado: (2014)

Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ
por: Jiang, YunQing, et al.
Publicado: (2014)

VAV3 Oncogene Expression in Colorectal Cancer: Clinical Aspects and Functional Characterization
por: Uen, Yih-Huei, et al.
Publicado: (2015)

VAV Proteins as Double Agents in Cancer: Oncogenes with Tumor Suppressor Roles
por: Cuadrado, Myriam, et al.
Publicado: (2021)

Mutation of Vav1 adaptor region reveals a new oncogenic activation
por: Razanadrakoto, Lyra, et al.
Publicado: (2014)

Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes
por: Shalom, Batel, et al.
Publicado: (2018)

Unraveling the Oncogenic Potential of VAV1 in Human Cancer: Lessons from Mouse Models
por: Shalom, Batel, et al.
Publicado: (2023)

Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors
por: Perretta-Tejedor, Nuria, et al.
Publicado: (2017)

A novel oncogenic enhancer of estrogen receptor-positive breast cancer
por: Bao, Chunjie, et al.
Publicado: (2022)

Corrigendum: Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors
por: Perretta-Tejedor, Nuria, et al.
Publicado: (2018)

VAV2 and VAV3 as Candidate Disease Genes for Spontaneous Glaucoma in Mice and Humans
por: Fujikawa, Keiko, et al.
Publicado: (2010)

High-mobility group A1 proteins may be involved in estrogen receptor status of breast cancer
por: Harada, Yoshihiro, et al.
Publicado: (2020)

VAV3 mediates resistance to breast cancer endocrine therapy
por: Aguilar, Helena, et al.
Publicado: (2014)

Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-α positive breast cancer?
por: Shupnik, Margaret A
Publicado: (2007)

Vav2 is required for cell spreading
por: Marignani, Paola A., et al.
Publicado: (2001)

Vav Proteins' Role in Skin Cancer
por: Mejia, Robin
Publicado: (2013)

Estrogen receptor α is involved in the regulation of ITGA8 methylation in estrogen receptor-positive breast cancer
por: Wu, Jingxun, et al.
Publicado: (2020)

The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function
por: Lorenzo-Martín, L. Francisco, et al.
Publicado: (2022)

The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis
por: Zatula, Nathalie, et al.
Publicado: (2014)

Differential effects of Vav‐promoter‐driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis
por: Tuzlak, Selma, et al.
Publicado: (2018)

Leptin is overexpressed in the tumor microenvironment of obese patients with estrogen receptor positive breast cancer
por: Hosney, Mohamed, et al.
Publicado: (2017)

Estrogen and Estrogen Receptor Modulators: Potential Therapeutic Strategies for COVID-19 and Breast Cancer
por: Hu, Shuying, et al.
Publicado: (2022)

Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma
por: Cortes, Jose R., et al.
Publicado: (2022)

Vav Regulates Peptide-specific Apoptosis in Thymocytes
por: Kong, Young-Yun, et al.
Publicado: (1998)

The Vav GEF Family: An Evolutionary and Functional Perspective
por: Rodríguez-Fdez, Sonia, et al.
Publicado: (2019)

The Rho Exchange Factors Vav2 and Vav3 Favor Skin Tumor Initiation and Promotion by Engaging Extracellular Signaling Loops
por: Menacho-Márquez, Mauricio, et al.
Publicado: (2013)

Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia
por: Nomura, Takeo, et al.
Publicado: (2013)

Tyrosine Phosphorylation of the Proto‐oncogene Product Vav and Its Association with the Adapter Grb2/Ash in a Human Leukemia Cell Line UT‐7
por: Hanazono, Yutaka, et al.
Publicado: (1995)

ZNF703 Overexpression may act as an oncogene in non‐small cell lung cancer
por: Baykara, Onur, et al.
Publicado: (2016)

Integrin-Linked Kinase Overexpression and Its Oncogenic Role in Promoting Tumorigenicity of Hepatocellular Carcinoma
por: Chan, Jenny, et al.
Publicado: (2011)

Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer
por: Switzer, Christopher H, et al.
Publicado: (2012)

Vav1 Is a Component of Transcriptionally Active Complexes
por: Houlard, Martin, et al.
Publicado: (2002)

Mechanism and function of Vav1 localisation in TCR signalling
por: Ksionda, Olga, et al.
Publicado: (2012)

VAV1 Gene Polymorphisms in Patients with Rheumatoid Arthritis
por: Pawlik, Andrzej, et al.
Publicado: (2020)

Vav1 Promotes B-Cell Lymphoma Development
por: Shalom, Batel, et al.
Publicado: (2022)

Overexpression of claudin-4 may be involved in endometrial tumorigenesis
por: PAN, XIAO-YU, et al.
Publicado: (2013)

A Universal Calibration Device for an Air Flow Sensor of the VAV Terminal Unit
por: Zhang, Heng, et al.
Publicado: (2022)

Vav3 Modulates B Cell Receptor Responses by Regulating Phosphoinositide 3-Kinase Activation
por: Inabe, Kazunori, et al.
Publicado: (2002)

Vav1 Fine Tunes p53 Control of Apoptosis versus Proliferation in Breast Cancer
por: Sebban, Shulamit, et al.
Publicado: (2013)

Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer
por: S Katzenellenbogen, Benita, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_dohol71lajb9gpkb8p73e6ajgm